Welcome to our dedicated page for American Well SEC filings (Ticker: AMWL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Well Corporation filings document the company’s SaaS-based technology-enabled healthcare platform, operating results, customer agreements, governance, and equity-compensation structure. Its Form 8-K filings include earnings reports for quarterly and annual periods, material definitive agreements, board changes, and related exhibit disclosures.
AMWL filings also describe commercial arrangements tied to digital care delivery, including the company’s operation of a white-labeled platform under the LiveHealth Online brand for Elevance Health and related clinical-provider access through Online Care Group. Proxy materials cover director elections, executive compensation, equity awards, stockholder voting matters, and board governance for the public company.
American Well Corp Chief Accounting Officer Paul Francis McNeice reported a small, non-discretionary stock sale. On April 1, 2026, he sold 383 shares of Class A Common Stock at $5.30 per share to cover tax liabilities from vesting restricted stock units. After this sell-to-cover transaction, he directly holds 10,616 shares of American Well Corp.
American Well Corporation reports that board member Dr. Peter Slavin has notified the company he will resign from its Board of Directors, effective at the company’s next annual meeting of stockholders in 2026. He will continue to serve as a director until that meeting.
The company states that Dr. Slavin’s decision is due to his transition to a new role on the West Coast of the United States and is not the result of any disagreement regarding American Well’s operations, policies, or procedures. The company expresses appreciation for his more than nine years of board service.
American Well Corporation (AMWL) submitted a Form 144 notice reporting proposed transactions in Class A Common Stock tied to an RSU vesting event dated 04/01/2026. The filing lists share counts associated with the vesting and recent sales by Phyllis Gotlib on 01/02/2026 and 03/02/2026.
American Well Corporation filing a Form 144 shows 11,831 Class A common shares vested from a restricted stock unit grant on 04/01/2026 and discloses prior sales: 2,472 shares sold on 03/02/2026 for $14,090.40 and 6,243 shares sold on 01/02/2026 for $30,284.79.
HIRSCHHORN MARK reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp reported that its Chief Financial Officer, Mark Hirschhorn, received an equity award tied to 50,413 shares of Class A common stock on March 4, 2026. The award was granted at no cash cost per share.
According to the footnote, this represents a grant of restricted stock units that will vest in equal quarterly installments over a two-year period, starting on the first calendar day of the month after three months from the grant date. Following this award, Hirschhorn directly holds 253,999 shares of Class A common stock.
American Well Corp executive Phyllis Gotlib reported an equity award of company stock. She acquired 50,413 shares of Class A Common Stock as a grant of restricted stock units with a stated price of $0.00 per share. Following this award, she directly holds 166,710 shares.
The RSUs will vest in equal quarterly installments over a two-year period, beginning on the first calendar day of the month after three months from the grant date and continuing until fully vested after 24 months. In addition, 114,250 shares are reported as indirectly owned through her husband.
American Well Corp (AMWL) reported that Chief Product & Tech. Officer Dmitry Zamansky acquired 50,413 shares of Class A Common Stock through a grant or award on March 4, 2026 at a price of $0.00 per share. After this transaction, his directly owned stake in Class A Common Stock totaled 246,655 shares.
According to the footnote, this award represents restricted stock units (RSUs) that vest in equal quarterly installments over two years. Vesting begins on the first calendar day of the month after three months from the grant date and continues quarterly until the first calendar day of the month following the 24‑month anniversary.
McNeice Paul Francis reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp Chief Accounting Officer Paul Francis McNeice reported an equity award of 8,066 shares of Class A common stock on a grant basis at $0.0000 per share. After this grant, he directly holds 10,999 shares of Class A common stock.
The award represents restricted stock units that will vest in equal quarterly installments over two years. Vesting begins on the first calendar day of the month after three months from the grant date and continues until the month following the 24‑month anniversary.
American Well Corp Chief Product & Tech. Officer Dmitry Zamansky sold 2,472 shares of Class A common stock in an open-market transaction at $5.45 per share. The trade was executed under a Rule 10b5-1 trading plan adopted on December 1, 2025, leaving him with 196,242 directly owned shares.
American Well Corp Chief Financial Officer Mark Hirschhorn reported an open-market sale of 10,796 shares of Class A common stock at $5.24 per share. According to the filing, the sale was an automatic “sell to cover” transaction to pay taxes on restricted stock units that vested on March 1, 2026, and not a discretionary trade. After this tax-related sale, he directly holds 203,586 shares.